Experience

AstraZeneca LP v. SigmaPharm Laboratories

AstraZeneca LP

SigmaPharm Laboratories

Representing AstraZeneca in Hatch-Waxman litigations against several defendants involving the blood-thinning drug Brilinta®.

AstraZeneca LP v. SigmaPharm Laboratories, 1:15-cv-01000, D. Del., Judge Andrews

Related Professionals

Mark J. Feldstein, Ph.D.
Partner
Washington, DC
+1 202 408 4092
Email
Ryan P. O'Quinn, Ph.D.
Partner
Reston, VA
+1 571 203 2426
Email
Yieyie Yang, Ph.D.
Partner
Washington, DC
+1 202 216 5170
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.

Novartis Pharmaceuticals Corporation et al.

Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.

Duchesnay Inc.

Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.

Grünenthal GmbH et al.

BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.

BioDelivery Sciences International, Inc. et al.

CMC Materials, LLC v. Dupont de Nemours, Inc. et al.

Dupont de Nemours, Inc. et al.

Biogen Int’l GmbH v. Amneal Pharmaceuticals LLC et al.

Biogen Int’l GmbH

Pioneer Hi-Bred International, Inc. et al. v. Syngenta Seeds, LLC

Pioneer Hi-Bred International, Inc. et al.

Salient Systems Corporation v. Hawk Technology Systems LLC et al.

Salient Systems Corporation

Corteva Agriscience LLC v. Monsanto Company et al.

Corteva Agriscience LLC

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.